| Company Name: |
BOC Sciences |
| Tel: |
1-631-485-4226; 16314854226 |
| Email: |
info@bocsci.com |
(-)-6-8-DIFLUORO-2,3,4,9-TETRAHYDRO-9-[[4-(METHYLSULFONYL)PHENYL]METHYL]-1H-CARBAZOLE-1-ACETIC ACID manufacturers
- L-670,596
-
- $2500.00
-
2026-05-21
- CAS:121083-05-4
- Purity:
- Supply Ability: 10g
|
| | (-)-6-8-DIFLUORO-2,3,4,9-TETRAHYDRO-9-[[4-(METHYLSULFONYL)PHENYL]METHYL]-1H-CARBAZOLE-1-ACETIC ACID Basic information |
| Product Name: | (-)-6-8-DIFLUORO-2,3,4,9-TETRAHYDRO-9-[[4-(METHYLSULFONYL)PHENYL]METHYL]-1H-CARBAZOLE-1-ACETIC ACID | | Synonyms: | L-670,596;(-)-6-8-DIFLUORO-2,3,4,9-TETRAHYDRO-9-[[4-(METHYLSULFONYL)PHENYL]METHYL]-1H-CARBAZOLE-1-ACETIC ACID;2-(6,8-Difluoro-9-(4-(methylsulfonyl)benzyl)-2,3,4,9-tetrahydro-1H-carbazol-1-yl)acetic acid;L670,596,L 670,596;(-)-6-8-Difluoro-2,3,4,9-tetrahydro-9-[[4-(Methylsulfonyl)phenyl]Methyl]-1H-carbazole-1-aceticacid | | CAS: | 121083-05-4 | | MF: | C22H21F2NO4S | | MW: | 433.47 | | EINECS: | | | Product Categories: | Prostanoid receptor and related | | Mol File: | 121083-05-4.mol | ![(-)-6-8-DIFLUORO-2,3,4,9-TETRAHYDRO-9-[[4-(METHYLSULFONYL)PHENYL]METHYL]-1H-CARBAZOLE-1-ACETIC ACID Structure](CAS/GIF/121083-05-4.gif) |
| | (-)-6-8-DIFLUORO-2,3,4,9-TETRAHYDRO-9-[[4-(METHYLSULFONYL)PHENYL]METHYL]-1H-CARBAZOLE-1-ACETIC ACID Chemical Properties |
| Boiling point | 693.4±55.0 °C(Predicted) | | density | 1.43±0.1 g/cm3(Predicted) | | storage temp. | Store at RT | | solubility | Soluble to 100 mM in 1.1eq. NaOH | | form | Powder | | pka | 4.56±0.10(Predicted) |
| | (-)-6-8-DIFLUORO-2,3,4,9-TETRAHYDRO-9-[[4-(METHYLSULFONYL)PHENYL]METHYL]-1H-CARBAZOLE-1-ACETIC ACID Usage And Synthesis |
| Uses | L-670,596 is a potent and selective thromboxane/prostaglandin endoperoxide receptor antagonist. | | Definition | ChEBI: 2-[6,8-difluoro-9-[(4-methylsulfonylphenyl)methyl]-1,2,3,4-tetrahydrocarbazol-1-yl]acetic acid is a member of carbazoles. | | Biological Activity | Potent and selective thromboxane A 2 /prostaglandin endoperoxide receptor antagonist (IC 50 = 5.5 nM). Inhibits U-44069-induced contractions of guinea pig trachea (pA 2 = 9.0) and human platelet aggregation in vitro (IC 50 = 6.5 nM). Also prevents thromboxane-mediated endothelial cell death. Orally active in vivo . | | in vivo | L-670596 (0.03mg/kg ; i.v.; single) inhibits arachidonic acid and U-44069 induced bronchoconstriction in the guinea pig[1].
L-670596 (2 mg/kg; i.v.; single) inhibits platelet aggregation to collagen in pigs[2]. | Animal Model: | Guinea pig (arachidonic acid and U-44069 induced bronchoconstriction model)[1]. | | Dosage: | 0.03mg/kg | | Administration: | Intravenous injection; single. | | Result: | Inhibited arachidonic acid and U-44069 induced bronchoconstriction. |
|
| | (-)-6-8-DIFLUORO-2,3,4,9-TETRAHYDRO-9-[[4-(METHYLSULFONYL)PHENYL]METHYL]-1H-CARBAZOLE-1-ACETIC ACID Preparation Products And Raw materials |
|